Compounds > iproniazid
Page last updated: 2024-10-29

iproniazid and Obesity

iproniazid has been researched along with Obesity in 2 studies

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HUSQUINET, H1
Bray, GA1
York, DA1

Other Studies

2 other studies available for iproniazid and Obesity

ArticleYear
[REMARKS ON THE ACTION OF IPRONIAZID (MARSILID) IN DEPRESSIVE SYNDROMES].
    Acta neurologica et psychiatrica Belgica, 1963, Volume: 63

    Topics: Depression; Depressive Disorder; Edema; Iproniazid; Obesity; Suicide; Toxicology

1963
Studies on food intake of genetically obese rats.
    The American journal of physiology, 1972, Volume: 223, Issue:1

    Topics: Animals; Cold Temperature; Dextroamphetamine; Diet; Environment; Feeding Behavior; Food Preferences;

1972